Study of BRY812 for advanced gynecological cancers
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests an experimental drug called BRY812 for people with advanced ovarian, endometrial, or ovarian clear cell cancer. The drug targets a protein called LIV-1 on cancer cells and may help shrink tumors or slow their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have advanced ovarian, endometrial, or ovarian clear cell cancer that has spread and is not responding to standard treatment.
- You have had 1 to 3 prior lines of cancer treatment (depending on the cancer type).
- Your tumor tests positive for a protein called LIV-1 (a lab test will confirm this).
- You have at least one tumor that can be measured on a scan.
- You are generally well enough to be up and about (ECOG 0 or 1).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SKB518, either alone or with other treatments, for people with advanced gynecologic cancers (ovarian, cervical, or endometrial) who have already had some treatment. It aims to see if the drug helps shrink or control the cancer.
This trial tests an experimental drug called BRY812 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective against a protein called LIV-1 found on some cancer cells.
This Phase 1/2 study tests BL-B01D1 in people with recurrent or metastatic gynecologic cancers (such as ovarian, uterine, or cervical cancer) when standard treatments have failed or aren’t options. It focuses on how well the drug works and whether it can be given safely.
This trial tests different doses of a new drug (BI 3820768) in people with advanced solid tumors, specifically germ cell tumors, endometrial cancer, or ovarian cancer. The goal is to see if the drug is safe and how well it works.
This study tests an experimental drug called AL58805 for people with advanced cancers of the uterus, cervix, soft tissue, or breast that have not responded to standard treatments. The drug is taken as a pill and may work by blocking pathways that help tumors grow.
This trial tests a new targeted drug (LY4175408) for people with certain advanced solid tumors (lung, endometrial, or triple negative breast cancer) who have already tried standard treatments. The goal is to see if the drug is safe and effective.
Hear when a new Advanced Gynecological Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.